Disputes Between South Korean Local Drug Makers And Multinationals Increasing, Expected To Get Worse
This article was originally published in The Pink Sheet Daily
Executive Summary
Pending free trade agreement gives multinationals 20 years of patent protection, a long wait to make generics.